Anthropic caught scientists using Claude to further biological weapon research58m ago Oracle says AI will save it from the SaaSpocalypse, not bring it on1h ago Congress Is Suddenly Waking Up to the AI Doomsday Threat2h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself2h ago Extreme Networks’ Agent ONE Coworker moves AI networking from dashboards to answers2h ago Introducing ChatGPT for Financial Services2h ago Tesla unveils driverless Cybercab in Japan for 1st time2h ago The AI safety vibe shift3h ago Sam Altman met with top power utilities about securing the electrical grid. He offered one possible solution: OpenAI's cyber services.3h ago OpenAI Is Open to Slowing Cutting-Edge AI, CEO Sam Altman Tells Staff3h ago Tencent-Backed Chipmaker Enflame Jumps 188% in Shanghai Debut3h ago Salesforce introduces Enterprise AI Harness, AI Control Plane3h ago The Race for the Next Big Weight-Loss Drug Is On—and China Wants In4h ago How Social Media Platforms Are Identifying AI Content4h ago

Anthropic caught scientists using Claude to further biological weapon research58m ago Oracle says AI will save it from the SaaSpocalypse, not bring it on1h ago Congress Is Suddenly Waking Up to the AI Doomsday Threat2h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself2h ago Extreme Networks’ Agent ONE Coworker moves AI networking from dashboards to answers2h ago Introducing ChatGPT for Financial Services2h ago Tesla unveils driverless Cybercab in Japan for 1st time2h ago The AI safety vibe shift3h ago Sam Altman met with top power utilities about securing the electrical grid. He offered one possible solution: OpenAI's cyber services.3h ago OpenAI Is Open to Slowing Cutting-Edge AI, CEO Sam Altman Tells Staff3h ago Tencent-Backed Chipmaker Enflame Jumps 188% in Shanghai Debut3h ago Salesforce introduces Enterprise AI Harness, AI Control Plane3h ago The Race for the Next Big Weight-Loss Drug Is On—and China Wants In4h ago How Social Media Platforms Are Identifying AI Content4h ago

Healthcare AI Research6 min reading time

Anthropic wants to develop its own drugs

The VergePublished Jul 3, 2026

Anthropic introduced Claude Science, an AI platform integrating tools and data for scientific research, and announced plans to develop drugs targeting neglected diseases. This marks a rare move for a major AI company to directly engage in drug development, alongside its existing biotech customers.

More on this story

Anthropic’s Claude Science bets on workflow, not a new model, to win over scientists
Jun 30· 2 sources

#anthropic #biotech #claude-science #drug-development #neglected-diseases #pharma

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes8h ago

Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch6h ago

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources1d ago